A Novel and Highly Selective Epidermal Growth Factor Receptor Inhibitor, SMUZ106, for the Treatment of Glioblastoma

Ying Jiang(University of Macau), Shanhe Wan(Southern Medical University)
Pharmaceutics
May 15, 2023
Cited by 5


Related Papers